Company profile: Roxwood Medical
1.1 - Company Overview
Company description
- Provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease, offering solutions in interventional cardiology, endovascular therapy, PCI, and critical limb ischemia.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Roxwood Medical
Silvergate Pharmaceuticals
HQ: United States
Website
- Description: Provider of pediatric medications, developing and commercializing innovative oral solutions that improve dosing accuracy, safety, and availability. Products include Xatmep (methotrexate) for pediatric acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis; Qbrelis (lisinopril) for hypertension (adults/pediatric 6+), adjunct heart failure, and acute MI in adults; and EPANED (enalapril) for hypertension (adults/pediatric >1 month), symptomatic heart failure, and asymptomatic left ventricular dysfunction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Silvergate Pharmaceuticals company profile →
SonoVol
HQ: United States
Website
- Description: Provider of a fully-automated benchtop ultrasound platform designed to lower the barrier of entry for biologists performing preclinical screening or acquiring longitudinal in vivo data across pharmaceutical, biotech, government, and academic markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SonoVol company profile →
Infraredx
HQ: United States
Website
- Description: Provider of catheter-based coronary imaging devices utilizing near-infrared spectroscopy (NIRS) to identify and characterize vulnerable plaque, alongside CME-accredited webinar and educational sessions on polyvascular disease management, intravascular coronary imaging, coronary physiology, patient risk assessment, and imaging-guided interventions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Infraredx company profile →
Mezzion Pharma
HQ: United States
Website
- Description: Provider of pharmaceuticals developing and discovering medicines, including JURVIGO (udenafil), a medication to improve physiology and exercise capacity in patients aged 12+ with Fontan circulation. Supports clinical programs: FUEL-2 phase 3 trial evaluating udenafil in adolescents 12–18, FALD study on long-term liver effects, and FUEL OLE study on long-term safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mezzion Pharma company profile →
Inovise
HQ: United States
Website
- Description: Provider of diagnostic medical technology focused on diagnostic cardiology, patient monitoring, and biomedical engineering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inovise company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Roxwood Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Roxwood Medical
2.2 - Growth funds investing in similar companies to Roxwood Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Roxwood Medical
4.2 - Public trading comparable groups for Roxwood Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →